Dow Down0.05% Nasdaq Down0.08%

Osiris Therapeutics, Inc. (OSIR)

-NasdaqGM
5.18 Up 0.11(2.17%) May 23, 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingSep 30, 2015Jun 30, 2015Mar 31, 2015Dec 31, 2014
Total Revenue 22,586   23,688   21,003   19,319  
Cost of Revenue5,071  5,142  4,609  4,250  
Gross Profit 17,515   18,546   16,394   15,069  
Operating Expenses
Research Development2,306  2,287  1,640  3,930  
Selling General and Administrative16,653  14,526  12,911  9,963  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (1,444) 1,733   1,843   1,176  
Income from Continuing Operations
Total Other Income/Expenses Net(1,100)(202)146  (8)
Earnings Before Interest And Taxes(2,544)1,531  1,989  1,168  
Interest Expense -   -   -   -  
Income Before Tax(2,544)1,531  1,989  1,168  
Income Tax Expense(625)367  612  89  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(1,919)1,164  1,377  1,079  
Non-recurring Events
Discontinued Operations -   -   -  (263)
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (1,919) 1,164   1,377   816  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (1,919) 1,164   1,377   816  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.